The burden of RSV Disease and new intervention strategies
Respiratory Virus Summit 2023
21 June 2023, Brussels and Online
ESWI is delighted to present the 2023 Respiratory Virus Summit on the Burden of Disease and New Intervention Strategies. The idea for the event stems from the increased rates of RSV infections, and from the rapid pace of new technical and vaccine developments. Therefore ESWI believes the timing is right to put a specific spotlight on RSV - and in particular on the Science-and-Policy Interface of RSV - this year.
Respiratory Syncytial Virus (RSV) is a common virus that affects all age groups with varying clinical effects. The virus is transmitted easily through coughing and sneezing with droplets containing the virus. RSV disease is a major burden in young children and older adults, causing hospitalisation and in acute cases, death.
Prevention and treatment strategies could be available soon as multiple clinical trials are being held and are showing a high efficacy.
Following up on our 2021 Webinar “RSV in a COVID-19 era”, ESWI will be organising a one day hybrid summit focusing on the health and economic burden of RSV disease and the prospect of possible solutions in the upcoming years.
Attendance of the hybrid Summit is free of charge but registration is mandatory. A limited number of live seats are available. Following by live stream is unlimited.